Winston Pharmaceuticals, Inc.
WPHM · OTC
12/31/2009 | 12/31/2008 | 9/30/2007 | 9/30/2006 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 208.2% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $0 | $0 | -$0 |
| % Margin | 99.4% | 98.1% | – | – |
| R&D Expenses | $2 | $3 | $0 | $0 |
| G&A Expenses | $2 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $6 | $0 | $0 |
| Operating Income | -$3 | -$5 | -$0 | -$0 |
| % Margin | -196.6% | -1,156.6% | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$3 | -$5 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$5 | -$0 | -$0 |
| % Margin | -190.4% | -1,136.2% | – | – |
| EPS | -0.04 | -0.1 | -0.08 | -0.8 |
| % Growth | 60% | -25% | 90% | – |
| EPS Diluted | -0.04 | -0.1 | -0.08 | -0.8 |
| Weighted Avg Shares Out | 61 | 53 | 2 | 1 |
| Weighted Avg Shares Out Dil | 61 | 53 | 2 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$5 | -$0 | -$0 |
| % Margin | -195.9% | -1,154.7% | – | – |